Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Henderson, Andrew"" wg kryterium: Autor


Wyświetlanie 1-8 z 8
Tytuł:
Virally Suppressed People Living with HIV Who Use Opioids Have Diminished Latency Reversal.
Autorzy:
Basukala B; Department of Biology, Boston University, Boston, MA 02215, USA.
Rossi S; Clinical Addiction Research and Education (CARE) Unit, Department of Medicine, Section of General Internal Medicine, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.
Bendiks S; Clinical Addiction Research and Education (CARE) Unit, Department of Medicine, Section of General Internal Medicine, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.
Gnatienko N; Clinical Addiction Research and Education (CARE) Unit, Department of Medicine, Section of General Internal Medicine, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.
Patts G; Biostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, MA 02118, USA.
Krupitsky E; Laboratory of Clinical Pharmacology of Addictions, Pavlov First St. Petersburg State Medical University, Saint-Petersburg 197022, Russia.; Department of Addictions, Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg 192019, Russia.
Lioznov D; Laboratory of Clinical Pharmacology of Addictions, Pavlov First St. Petersburg State Medical University, Saint-Petersburg 197022, Russia.
So-Armah K; Clinical Addiction Research and Education (CARE) Unit, Department of Medicine, Section of General Internal Medicine, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.
Sagar M; Department of Medicine, Section of Infectious Diseases, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.; Department of Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.
Cheng C; Department of Biology, Boston University, Boston, MA 02215, USA.; Department of Psychiatry, University of California San Diego, La Jolla, CA 92093, USA.
Henderson AJ; Department of Medicine, Section of Infectious Diseases, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.; Department of Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Feb 01; Vol. 15 (2). Date of Electronic Publication: 2023 Feb 01.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
HIV Infections*/drug therapy
HIV-1*
Humans ; Analgesics, Opioid/pharmacology ; Leukocytes, Mononuclear ; Virus Latency ; Proviruses/genetics
Czasopismo naukowe
Tytuł:
Defective HIV-1 genomes and their potential impact on HIV pathogenesis.
Autorzy:
Kuniholm J; Department of Microbiology, Section of Infectious Diseases, Boston University School of Medicine, Boston, MA, 02116, USA.
Coote C; Department of Medicine, Section of Infectious Diseases, Boston University School of Medicine, Boston, MA, 02116, USA.
Henderson AJ; Department of Microbiology, Section of Infectious Diseases, Boston University School of Medicine, Boston, MA, 02116, USA. .; Department of Medicine, Section of Infectious Diseases, Boston University School of Medicine, Boston, MA, 02116, USA. .
Pokaż więcej
Źródło:
Retrovirology [Retrovirology] 2022 Jun 28; Vol. 19 (1), pp. 13. Date of Electronic Publication: 2022 Jun 28.
Typ publikacji:
Journal Article; Review; Research Support, N.I.H., Extramural
MeSH Terms:
HIV Infections*/genetics
HIV-1*/physiology
Genome, Viral ; Humans ; Proviruses/genetics ; Proviruses/metabolism
Czasopismo naukowe
Tytuł:
Intragenic proviral elements support transcription of defective HIV-1 proviruses.
Autorzy:
Kuniholm J; Boston University School of Medicine, Department of Microbiology, Boston, Massachusetts, United States of America.
Armstrong E; Boston University School of Medicine, Department of Medicine, Section of Infectious Diseases; Boston, Massachusetts, United States of America.
Bernabe B; Boston University School of Medicine Graduate Medical Sciences, Boston, Massachusetts, United States of America.
Coote C; Boston University School of Medicine, Department of Medicine, Section of Infectious Diseases; Boston, Massachusetts, United States of America.
Berenson A; Boston University, Department of Biology, Boston, Massachusetts, United States of America.
Patalano SD; Boston University, Department of Biology, Boston, Massachusetts, United States of America.
Olson A; Boston University School of Medicine, Department of Medicine, Section of Infectious Diseases; Boston, Massachusetts, United States of America.
He X; Boston University School of Medicine, Department of Medicine, Section of Infectious Diseases; Boston, Massachusetts, United States of America.
Lin NH; Boston University School of Medicine, Department of Medicine, Section of Infectious Diseases; Boston, Massachusetts, United States of America.
Fuxman Bass JI; Boston University, Department of Biology, Boston, Massachusetts, United States of America.
Henderson AJ; Boston University School of Medicine, Department of Microbiology, Boston, Massachusetts, United States of America.; Boston University School of Medicine, Department of Medicine, Section of Infectious Diseases; Boston, Massachusetts, United States of America.; Boston University School of Medicine Graduate Medical Sciences, Boston, Massachusetts, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2021 Dec 28; Vol. 17 (12), pp. e1009982. Date of Electronic Publication: 2021 Dec 28 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Genome, Viral/*genetics
HIV Infections/*virology
HIV-1/*genetics
Proviruses/*genetics
RNA, Viral/*genetics
Humans ; Macrophages/virology ; Polymerase Chain Reaction ; Transcription, Genetic ; env Gene Products, Human Immunodeficiency Virus/genetics ; nef Gene Products, Human Immunodeficiency Virus/genetics
Czasopismo naukowe
Tytuł:
Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9.
Autorzy:
Olson A; Department of Medicine and Microbiology, Boston University School of Medicine, Boston, MA 02118, USA.
Basukala B; Department of Biology, Boston University, Boston, MA 02215, USA.
Lee S; Biomedical Engineering and Biological Design Center, Boston University, Boston, MA 02215, USA.
Gagne M; Department of Medicine and Microbiology, Boston University School of Medicine, Boston, MA 02118, USA.
Wong WW; Biomedical Engineering and Biological Design Center, Boston University, Boston, MA 02215, USA.
Henderson AJ; Department of Medicine and Microbiology, Boston University School of Medicine, Boston, MA 02118, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2020 Oct 12; Vol. 12 (10). Date of Electronic Publication: 2020 Oct 12.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV-1/*genetics
Proviruses/*genetics
RNA, Guide, CRISPR-Cas Systems/*genetics
Virus Activation/*genetics
Virus Latency/*genetics
Acetylation ; CRISPR-Cas Systems ; Cell Line ; Clustered Regularly Interspaced Short Palindromic Repeats/genetics ; Epigenesis, Genetic/genetics ; HEK293 Cells ; HIV Infections/virology ; HIV Long Terminal Repeat/genetics ; Histones/metabolism ; Humans ; Jurkat Cells ; Methylation ; Repressor Proteins/metabolism ; Transcription, Genetic/genetics
Czasopismo naukowe
Tytuł:
Strength of T cell signaling regulates HIV-1 replication and establishment of latency.
Autorzy:
Gagne M; Department of Microbiology, Boston University School of Medicine, Boston, MA, United States of America.
Michaels D; Department of Microbiology, Boston University School of Medicine, Boston, MA, United States of America.; Department of Medicine, Section of Infectious Diseases, Boston University Medical Center, Boston, MA, United States of America.
Schiralli Lester GM; Department of Pediatrics, Neonatology, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, United States of America.
Gummuluru S; Department of Microbiology, Boston University School of Medicine, Boston, MA, United States of America.
Wong WW; Department of Biomedical Engineering, Boston University, Boston, MA, United States of America.; Biological Design Center, Boston University, Boston, MA, United States of America.
Henderson AJ; Department of Microbiology, Boston University School of Medicine, Boston, MA, United States of America.; Department of Medicine, Section of Infectious Diseases, Boston University Medical Center, Boston, MA, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2019 May 22; Vol. 15 (5), pp. e1007802. Date of Electronic Publication: 2019 May 22 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
CD4-Positive T-Lymphocytes/*immunology
CD4-Positive T-Lymphocytes/*virology
HIV Infections/*immunology
HIV Infections/*virology
HIV-1/*immunology
Proviruses/*immunology
Virus Latency/*immunology
Humans ; Jurkat Cells ; Signal Transduction ; Virus Activation/immunology ; Virus Replication/immunology
Czasopismo naukowe
Tytuł:
Identification of benzazole compounds that induce HIV-1 transcription.
Autorzy:
Graci JD; PTC Therapeutics, Inc., South Plainfield, New Jersey, United States of America.
Michaels D; Department of Medicine and Microbiology, Section of Infectious Diseases, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Chen G; PTC Therapeutics, Inc., South Plainfield, New Jersey, United States of America.
Schiralli Lester GM; Department of Pediatrics, Neonatology, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, New York, United States of America.
Nodder S; Department of Medicine and Microbiology, Section of Infectious Diseases, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Weetall M; PTC Therapeutics, Inc., South Plainfield, New Jersey, United States of America.
Karp GM; PTC Therapeutics, Inc., South Plainfield, New Jersey, United States of America.
Gu Z; PTC Therapeutics, Inc., South Plainfield, New Jersey, United States of America.
Colacino JM; PTC Therapeutics, Inc., South Plainfield, New Jersey, United States of America.
Henderson AJ; Department of Medicine and Microbiology, Section of Infectious Diseases, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 Jun 28; Vol. 12 (6), pp. e0179100. Date of Electronic Publication: 2017 Jun 28 (Print Publication: 2017).
Typ publikacji:
Journal Article
MeSH Terms:
Azoles/*pharmacology
Benzene/*pharmacology
HIV-1/*drug effects
Transcription, Genetic/*drug effects
Azoles/chemistry ; Benzene/chemistry ; Cell Line ; HIV-1/genetics ; Humans
Czasopismo naukowe
    Wyświetlanie 1-8 z 8

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies